Resolution of danazol-induced cholestasis with S-adenosylmethionine
article
OA: bronze
CC0
⤵ 4 in-corpus citations
AI-generated summary
Intravenous and oral S-adenosylmethionine treatment resolved jaundice and renal impairment in a patient experiencing danazol-induced cholestasis.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
In a case of danazol-induced cholestasis, the anti-cholestatic agent S-adenosylmethionine was given intravenously for 3 weeks and then orally for 6 weeks. This was well tolerated and led to prompt resolution of both jaundice and associated renal impairment.
My notes (saved in your browser only)
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (17)
- Danazol and Cholestatic Hepatitis via openalex
- DANAZOL AND LIVER DAMAGE via openalex
- Danazol-induced cholestasis. via openalex
- Fulminant hepatic failure associated with aplastic anaemia after treatment with danazol. Case report via openalex
- Jaundice after danazol therapy for endometriosis. via openalex
- The use of an impeded androgen—danazol—in the management of benign breast disorders via openalex
- doi:10.7326/0003-4819-93-6-809 via openalex
- doi:10.2165/00003495-199000403-00011 via openalex
- doi:10.1016/0006-2952(90)90579-a via openalex
- doi:10.1002/hep.1840150220 via openalex
- doi:10.2165/00003495-199000403-00009 via openalex
- doi:10.1055/s-2008-1040487 via openalex
- W6650957546 via openalex
- W6655263789 via openalex
- doi:10.1097/00000441-198704000-00006 via openalex
- doi:10.1016/0168-8278(90)90077-5 via openalex
- doi:10.1056/nejm198306093082306 via openalex
Cited by (4)
Source provenance
- europepmc
- last seen: 2026-09-27T09:11:36.575535+00:00
- openalex
- last seen: 2026-05-10T11:14:42.433795+00:00
License: CC0
· commercial use OK